Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Jutant (Le Kremlin Bicêtre, France), X. Jaïs (Le Kremlin Bicêtre, France), B. Girerd (Paris, France), X. Mignard (Le Kremlin Bicêtre, France), M. Ghigna (Le Plessis Robinson, France), D. Bourlier (Bordeaux, France), C. Tromeur (Brest, France), E. Bergot (Caen, France), G. Prévot (Toulouse, France), C. Dauphin (Clermont Ferrand, France), N. Favrolt (Dijon, France), J. Traclet (Lyon, France), P. Moceri (Nice, France), T. Soumagne (Besançon, France), F. Bauer (Rouen, France), P. Degroote (Lille, France), C. Chabanne (Rennes, France), P. Magro (Tours, France), L. Bertoletti (Saint Etienne, France), L. Savale (Le Kremlin Bicêtre, France), F. Soubrier (Paris, France), G. Simonneau (Le Kremlin Bicêtre, France), O. Sitbon (Le Kremlin Bicêtre, France), P. Brillet (Bobigny, France), M. Humbert (Le Kremlin Bicêtre, France), D. Montani (Le Kremlin Bicêtre, France). Pulmonary hypertension associated with neurofibromatosis type 1: data from the French Pulmonary Hypertension Registry. 5456

Member's Comments

No comment yet.

Related content which might interest you: Long-term data from the Swiss pulmonary hypertension registry Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Pulmonary hypertension associated with neurofibromatosis type 1 Source: Eur Respir Rev, 27 (149) 180053; 10.1183/16000617.0053-2018 Year: 2018 Pulmonary hypertension in patients with neurofibromatosis type I Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Quality of life of patients with pulmonary arterial hypertension associated with congenital heart disease: The multicenter cross-sectional ACHILLE study Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Incident pulmonary arterial hypertension in a Brazilian reference center: Results of a four-year registry Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Pregnancy and pulmonary hypertension: Experience of a reference center in Brazil Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Pulmonary arterial hypertension – A single-centre experience Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Characteristics of patients with pulmonary hypertension in end stage renal disease Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH). Source: International Congress 2017 – PAH and CTEPH Year: 2017 Female pulmonary arterial hypertension is associated with decreased microRNA96 expression Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Portopulmonary hypertension in United Kingdom: A contemporary, national, observational study Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Sarcoidosis-associated Pulmonary Hypertension: A London Cohort Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Epoprostenol dosing by concomitant therapies in the PROSPECT registry Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Immune signatures in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Smad1 deficiency and female gender contribute to the development of pulmonary hypertension Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Nebivolol and pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 HbA1c-levels in patients with operable chronic thromboembolic pulmonary hypertension Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014